DK1554259T3 - Nye bicykliske inhibitorer af hormonsensitive lipaser - Google Patents

Nye bicykliske inhibitorer af hormonsensitive lipaser

Info

Publication number
DK1554259T3
DK1554259T3 DK03808700T DK03808700T DK1554259T3 DK 1554259 T3 DK1554259 T3 DK 1554259T3 DK 03808700 T DK03808700 T DK 03808700T DK 03808700 T DK03808700 T DK 03808700T DK 1554259 T3 DK1554259 T3 DK 1554259T3
Authority
DK
Denmark
Prior art keywords
hormone
novel bicyclic
bicyclic inhibitors
sensitive lipases
lipases
Prior art date
Application number
DK03808700T
Other languages
Danish (da)
English (en)
Inventor
Stefan Petry
Karl-Heinz Baringhaus
Norbert Tennagels
Guenter Mueller
Hubert Heuer
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1554259T3 publication Critical patent/DK1554259T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18Benzotriazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK03808700T 2002-10-12 2003-09-27 Nye bicykliske inhibitorer af hormonsensitive lipaser DK1554259T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10247680A DE10247680B4 (de) 2002-10-12 2002-10-12 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
PCT/EP2003/010765 WO2004035550A1 (de) 2002-10-12 2003-09-27 Neue bicyclische inhibitoren der hormon sensitiven lipase

Publications (1)

Publication Number Publication Date
DK1554259T3 true DK1554259T3 (da) 2007-05-07

Family

ID=32038583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03808700T DK1554259T3 (da) 2002-10-12 2003-09-27 Nye bicykliske inhibitorer af hormonsensitive lipaser

Country Status (38)

Country Link
EP (1) EP1554259B1 (sr)
JP (2) JP4658607B2 (sr)
KR (1) KR20050059254A (sr)
CN (1) CN100366616C (sr)
AR (1) AR041565A1 (sr)
AT (1) ATE349433T1 (sr)
AU (1) AU2003275997B8 (sr)
BR (1) BR0315257A (sr)
CA (1) CA2501734C (sr)
CR (1) CR7717A (sr)
CY (1) CY1106358T1 (sr)
DE (2) DE10247680B4 (sr)
DK (1) DK1554259T3 (sr)
EC (1) ECSP055729A (sr)
ES (1) ES2277152T3 (sr)
GT (1) GT200300214A (sr)
HN (1) HN2003000316A (sr)
HR (1) HRP20050325A2 (sr)
IL (1) IL167907A (sr)
JO (1) JO2497B1 (sr)
MA (1) MA27404A1 (sr)
MX (1) MXPA05003359A (sr)
MY (1) MY138057A (sr)
NO (1) NO20052291L (sr)
OA (1) OA12941A (sr)
PA (1) PA8585101A1 (sr)
PE (1) PE20040776A1 (sr)
PL (1) PL374605A1 (sr)
PT (1) PT1554259E (sr)
RS (1) RS51543B (sr)
RU (1) RU2325385C2 (sr)
SV (1) SV2004001633A (sr)
TN (1) TNSN05105A1 (sr)
TW (1) TWI313265B (sr)
UA (1) UA79994C2 (sr)
UY (1) UY28015A1 (sr)
WO (1) WO2004035550A1 (sr)
ZA (1) ZA200501757B (sr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005002130A1 (de) 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
DE102005026808A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026809A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005048897A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049954A1 (de) * 2005-10-19 2007-05-31 Sanofi-Aventis Deutschland Gmbh Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049953A1 (de) 2005-10-19 2007-04-26 Sanofi-Aventis Deutschland Gmbh Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
FR2915197B1 (fr) * 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
FR2915199B1 (fr) 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
FR2915198B1 (fr) 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
BR122013027950A2 (pt) * 2008-12-24 2019-12-10 BIAL PORTELA & Cª S A compostos farmacêuticos
US8329904B2 (en) 2009-05-12 2012-12-11 Hoffmann-La Roche Inc. Azacyclic derivatives
US8440710B2 (en) * 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US8097634B2 (en) * 2010-04-15 2012-01-17 Hoffmann-La Roche Inc. Azacyclic derivatives
WO2011140296A1 (en) * 2010-05-05 2011-11-10 Infinity Pharmaceuticals Triazoles as inhibitors of fatty acid synthase
US8722721B2 (en) * 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US8703807B2 (en) * 2011-03-17 2014-04-22 Hoffmann-La Roche Inc. Azaspirodecanone compounds
US8809384B2 (en) 2011-03-25 2014-08-19 Hoffmann-La Roche Inc. Azaspirodecanone compounds
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015089137A1 (en) 2013-12-11 2015-06-18 Karos Pharmaceuticals, Inc. Acylguanidines as tryptophan hydroxylase inhibitors
WO2016109501A1 (en) 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Amide compounds as tryptophan hydroxylase inhibitors
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
EP3880680A1 (en) 2018-11-14 2021-09-22 Altavant Sciences GmbH A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) for treating diseases or disorders associated with peripheral serotonin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1124716A (en) * 1978-10-20 1982-06-01 Michael J. Simons Blocked benzotriazole compounds as development restrainer precursors
US5369086A (en) * 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
IL158463A0 (en) * 2001-05-05 2004-05-12 Smithkline Beecham Plc N-aroyl cyclic amines
AU2002351732A1 (en) * 2001-12-14 2003-06-30 Novo Nordisk A/S Compositions decreasing activity of hormone-sensitive lipase

Also Published As

Publication number Publication date
ZA200501757B (en) 2005-09-07
PA8585101A1 (es) 2004-09-16
RS51543B (sr) 2011-06-30
KR20050059254A (ko) 2005-06-17
CY1106358T1 (el) 2011-10-12
TW200413335A (en) 2004-08-01
HK1080473A1 (en) 2006-04-28
UA79994C2 (en) 2007-08-10
JP2011026342A (ja) 2011-02-10
MXPA05003359A (es) 2005-06-22
ES2277152T3 (es) 2007-07-01
TWI313265B (en) 2009-08-11
JO2497B1 (en) 2009-10-05
IL167907A (en) 2010-12-30
CN100366616C (zh) 2008-02-06
MY138057A (en) 2009-04-30
CR7717A (es) 2007-09-14
DE50306134D1 (de) 2007-02-08
EP1554259B1 (de) 2006-12-27
ECSP055729A (es) 2005-07-06
PT1554259E (pt) 2007-02-28
AR041565A1 (es) 2005-05-18
RU2005114394A (ru) 2006-01-20
CN1688555A (zh) 2005-10-26
MA27404A1 (fr) 2005-06-01
BR0315257A (pt) 2005-08-23
NO20052291D0 (no) 2005-05-10
EP1554259A1 (de) 2005-07-20
CA2501734C (en) 2011-05-31
JP2006509734A (ja) 2006-03-23
JP4658607B2 (ja) 2011-03-23
WO2004035550A1 (de) 2004-04-29
RU2325385C2 (ru) 2008-05-27
GT200300214A (es) 2007-02-05
ATE349433T1 (de) 2007-01-15
DE10247680A1 (de) 2004-04-22
AU2003275997A1 (en) 2004-05-04
UY28015A1 (es) 2004-04-30
SV2004001633A (es) 2004-03-19
AU2003275997B8 (en) 2010-09-30
RS20050207A (sr) 2007-08-03
PL374605A1 (en) 2005-10-31
HRP20050325A2 (en) 2005-06-30
PE20040776A1 (es) 2004-12-24
NO20052291L (no) 2005-05-10
OA12941A (en) 2006-10-13
TNSN05105A1 (en) 2007-05-14
DE10247680B4 (de) 2005-09-01
HN2003000316A (es) 2006-06-12
AU2003275997B2 (en) 2010-03-25
CA2501734A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
DK1554259T3 (da) Nye bicykliske inhibitorer af hormonsensitive lipaser
NO20050072L (no) Nye inhibitorer av kinaser
DK1483284T3 (da) Selektive dipeptidinhibitorer af kallikrein
NO20045220L (no) Heterocykliske inhibitorer for kinaser
DK1532138T3 (da) Inhibitorer af tyrosinkinaser
DK1315694T3 (da) Inhibitorer af alpha-4-medieret celleadhæsion
EP1517904A4 (en) INHIBITORS OF MITOTIC KINESINE
EP1509507A4 (en) INHIBITORS OF MITOTIC KINESINE
SE530720E (sv) Förbehandling av flis med höggradig defibrering
EP1578724A4 (en) INHIBITORS OF MITOTIC KINESINE
EP1474093A4 (en) Granzyme B INHIBITORS
DK1567529T3 (da) Pseudopolymorfe former af en hiv-proteaseinhibitor
EE200300188A (et) Reumatoidartriidi raviks kasutatavad EP4 retseptori inhibiitorid
ATE269327T1 (de) Imidazol-5-yl-2-anilino-pyrimidine als inhibitoren der zellproliferation
DK2343275T3 (da) Krystallinsk form af optiske enantiomerer af modafinil
ATE557005T1 (de) Heterocyclo-hemmer der kaliumkanalfunktion
ATE428701T1 (de) Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
DE602004017623D1 (de) N-substituierte pyrazolyl-amidyl-benzimidazolyl-c-kit-inhibitoren
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
EP1660436A4 (en) cathepsin inhibitors
DK1307263T3 (da) Hidtil ukendt anvendelse af lipaseinhibitorer
DK1470732T3 (da) Fremskaffelse af lokaliseringsinformation
NO20050118D0 (no) Substituerte fenylsulfonamidinhibitorer av beta-amyolid produksjon
DK1451154T3 (da) Inhibitorer af cytosolisk phospholipase A2
EP1697331A4 (en) INHIBITORS OF MITOTIC KINESINE